Morgan Stanley GIFT Cures is a philanthropic collaboration with
Harrington Discovery Institute
Morgan Stanley today announced the launch of Morgan Stanley GIFT
Cures℠ powered by Harrington Discovery Institute, the first special
interest program of The Morgan Stanley Global Impact Funding Trust
(Morgan Stanley GIFT) that is dedicated to advancing the
development of research discoveries into new cures and treatments
for a broad range of diseases. The launch was announced at The
Exchange 2019 in New York, a two-day conference, June 4-5, hosted
by Morgan Stanley and Social Impact Exchange.
“We are excited to join forces with Harrington Discovery
Institute,” said Mandell Crawley, Head of Morgan Stanley Private
Wealth Management. “Sadly, there are far too many families around
the world that are impacted by a disease that has no cure or
meaningful treatment, including many of the most common diseases
affecting our society. The Morgan Stanley GIFT Cures program was
formed to address unmet medical need by helping to create new
medicines.”
Through a competitive application process, Harrington Discovery
Institute sources the most promising research from leading academic
institutions across the U.S., Canada and the UK that target novel
therapeutic approaches in any disease area. The combination of
Harrington Discovery Institute and Morgan Stanley GIFT Cures will
help provide the catalytic capital, expertise and management needed
to connect strategic philanthropists to drug discovery projects and
medical breakthroughs with the greatest potential for near-term
impact.
“With nearly two decades of experience working with the Firm’s
most dedicated philanthropists, Morgan Stanley GIFT recognized that
medical philanthropy wasn’t moving the needle for patients and
families with diseases despite the generosity of donors around the
world,” said Melanie Schnoll Begun, Head of Philanthropy
Management. “We are pleased to collaborate with Harrington
Discovery Institute to launch Morgan Stanley GIFT Cures, an
innovative special interest program Morgan Stanley GIFT created in
response to client demands for more concrete results from their
philanthropy in the search for cures.”
“Hundreds of millions of people suffer from diseases where cures
are not available, yet the knowledge to develop effective
treatments actually exists,” explains Dr. Jonathan Stamler,
President of Harrington Discovery Institute. “Breakthrough
discoveries remain on the shelves of research institutions because
the physicians and scientists making discoveries lack the drug
development expertise needed to translate their scientific
discoveries into new medicines.”
Harrington Discovery Institute was established in 2012 with a
$50 million gift from the Harrington Family, medical supply
entrepreneurs. The Institute was founded to create a new system for
developing breakthrough discoveries into medicines, primarily in
answer to two challenges: Why so many promising medical
breakthroughs fail to yield life-enhancing and life-saving new
drugs, and where financial and other resources should be invested
to improve and accelerate success.
Seven years later, Harrington Discovery Institute has become the
center of a rapidly growing global initiative to advance the most
promising new therapies through the drug development pipeline.
“We are pleased to collaborate with Morgan Stanley GIFT to grow
the community of philanthropists who are committed to supporting
the development of new medicines. From the start, we knew that
strategic partnerships like this would be instrumental in helping
expand Harrington Discovery Institute’s portfolio of
drugs-in-the-making and increase its impact on human health,” said
Ronald Harrington.
The Morgan Stanley GIFT Cures program provides opportunities for
philanthropists to augment the impact of their medically-related
giving, whether they wish to focus on a specific disease or across
a broader spectrum. It is also an opportunity to become part of a
donor community committed to creating the next generation of
breakthrough medicines, including learning best practices in
bringing breakthrough therapies to market and in healthcare giving
more broadly.
At launch, the Morgan Stanley GIFT Cures program is funding
multiple programs to advance treatment for:
- Alzheimer’s & Other Neurologic
Diseases
- Cancers
- Heart failure and Other Cardiovascular
Diseases
- Blindness
- Bone and Joint Diseases
- Diabetes
- Gastrointestinal Diseases
- All Infectious Diseases
- All Rare Diseases
- Asthma and Respiratory Diseases
- Immune and other Disorders
Morgan Stanley GIFT is an independent 501(c)(3) organization
that provides the Firm’s clients access to a donor advised fund,
supporting organizations, other planned giving strategies, client
events and experiences. Established in 2000; total grants to
charities have reached over $1.7 billion since inception. All funds
donated to Morgan Stanley GIFT Cures will be managed within the
Morgan Stanley GIFT donor advised fund to advance Harrington
Discovery Institute’s mission of advancing breakthrough scientific
discoveries throughout the U.S. and the UK into cures.
Morgan Stanley Wealth Management, a global leader, provides
access to a wide range of products and services to individuals,
businesses and institutions, including brokerage and investment
advisory services, financial and wealth planning, cash management
and lending products and services, annuities and insurance,
retirement and trust services.
Morgan Stanley (NYSE: MS) is a leading global financial services
firm providing investment banking, securities, wealth management
and investment management services. With offices in more than 41
countries, the Firm’s employees serve clients worldwide including
corporations, governments, institutions and individuals. For more
information about Morgan Stanley, please visit
www.morganstanley.com.
The Harrington Discovery Institute at University Hospitals in
Cleveland, OH – part of The Harrington Project for Discovery &
Development – aims to advance medicine and society by enabling our
nation’s most inventive scientists to turn their discoveries into
medicines that improve human health. The institute was created in
2012 with a $50 million founding gift from the Harrington family
and instantiates the commitment they share with University
Hospitals to a Vision for a ‘Better World’. For more information,
visit www.harringtondiscovery.org.
©2019 Morgan Stanley Smith Barney LLC. Member SIPC
CRC 2559978 6/2019
Disclosures: This material is for informational purposes only.
The information and data herein are believed to be reliable;
however, their accuracy and completeness is not guaranteed by
Morgan Stanley Smith Barney LLC (“Morgan Stanley”) and providing
you with this information is not to be considered a solicitation on
our part with respect to the purchase or sale of any securities,
investments, strategies or products that may be mentioned. In
addition, the information and data referenced is as of the date of
the material and subject to change without notice. Past performance
is not a guarantee of future results.
Morgan Stanley, its affiliates and Morgan Stanley Financial
Advisors and Private Wealth Advisors do not provide tax or legal
advice. Clients should consult their tax advisor for matters
involving taxation and tax planning and their attorney for matters
involving trust and estate planning, charitable giving,
philanthropic planning and other legal matters.
University Hospital of Cleveland, OH is a client of Morgan
Stanley. It is not known whether the client approves of Morgan
Stanley or the advisory services provided. Nothing in this material
is intended to imply any other affiliation, sponsorship,
endorsement, approval, investigation, verification or monitoring of
the Harrington Discovery Institute, University Hospital of
Cleveland, OH or any other entity referenced in this material.
The Morgan Stanley Global Impact Funding Trust, Inc. (“Morgan
Stanley GIFT, Inc.”) is an organization described in Section
501(c)(3) of the Internal Revenue Code of 1986, as amended. MS
Global Impact Funding Trust (“Morgan Stanley GIFT”) is a
donor-advised fund. Morgan Stanley provides investment management
services to Morgan Stanley GIFT.
While we believe that Morgan Stanley GIFT Cures provides a
valuable philanthropic opportunity, contributions to Morgan Stanley
GIFT Cures are not appropriate for everyone. Other forms of
charitable giving may be more appropriate depending on a donor’s
specific situation. Of critical importance to any person
considering making a donation to Morgan Stanley GIFT is the fact
that any such donation is an irrevocable contribution.
Back office administration provided by RenPSG, an unaffiliated
charitable gift administrator.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190604005987/en/
Media Relations: Christine Jockle, 914.225.6827,
Christine.Jockle@morganstanley.com
Morgan Stanley (NYSE:MS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Morgan Stanley (NYSE:MS)
Historical Stock Chart
From Mar 2023 to Mar 2024